Announcements
Harmonisation of the Care and Use of Fish in Research 23-26 May 2005 (Oslo, Norway) With the emergence of aquaculture in many countries, and increasing emphasis on marine ecotoxicology and genomics, large numbers of fish are being used worldwide. Thus there is a need both to exchange existing knowledge on the care and use of fish in research and to explore areas where our present knowledge is inadequate. The Laboratory Animal Unit at the Norwegian School of Veterinary Science has planned an international meeting in May 2005 to further these aims and has launched a website which it hopes will become a reference centre for information on the care and use of fish in research. There are already several detailed guidelines which deserve wider recognition, but it is important to reach consensus on welfare issues. We also hope to increase the exchange of knowledge between scientists and technicians using fish and the traditional laboratory animal species.
The meeting, entitlted 'Harmonisation of the Care and Use of Fish in Research' will be held on 23-26 May 2005 in Oslo. Much of the meeting will be in the form of a workshop where attendees will be asked to participate actively in small groups covering a wide range of issues. It will bring together experts from around the world and to exchange current information on how to apply the three Rs to the use of fish in research. Visit http://oslovet.veths.no/fish/ for more information.
1st East Mediterranean Regional ICLAS Symposium on Laboratory Animal Science 30-31 May 2005 (Athens, Greece) The 1st East Mediterranean ICLAS Symposium on Laboratory Animal Science is being organized jointly by the Center for Experimental Surgery of the Foundation of Biomedical Research of the Academy of Athens (www.bioacademy.gr), the International Council on Laboratory Animal Science (ICLAS) and the Hellenic Society for Biomedical and Laboratory Animal Science (HSBLAS). The Symposium will be held in Athens, Greece on 30-31 May 2005 . The registration fee for all participants is h150. A Poster Session is incorporated and the meeting will be attractive to laboratory animal scientists from Eastern Mediterranean countries, who will learn about and contribute to discussions on recent developments in laboratory animal science. The official language is English. Abstracts of papers and posters will be published in the proceedings of the Symposium. The meeting will focus on the following topics: Biomedicine 2005: 6th International Conference on Modelling in Medicine and Biology 7-9 September 2005 (Bologna, Italy) These conferences provide an internationally recognized forum for disseminating the latest bioengineering research and its applications. Topics will cover a broad spectrum, including the application of computers to simulate biomedical phenomena. Current medical and biological technology already appears to some as science fiction, but projections into the 21st century are even more ambitious and will result in substantial progress in health care and in the quality of life of the population. This is in great part due to interaction between medical sciences and engineering. This meeting will bring together medical and physical scientists and engineers who are interested in the latest developments on simulations in medicine. It will also be relevant to professionals working in medical enterprises, which are actively involved in this field. Attendance will:
Keep you up-to-date on the latest advances in the field.
Allow you to present your research within a unique forum.
Facilitate collaboration with experts from around the world. Occupational health and safety. Agricultural animal research programmes -a discussion of the role of the laboratory animal veterinarian.
Physical plant and facility planning.
Eighth Annual Conference on Vaccine Research
9-11 May 2005 (Baltimore, MD, USA) The remarkable pace of biotechnology discovery is continuing unabated. New cytokines are identified, immune regulatory pathways unravelled, promising adjuvants reported, and investigational products revealed to have high degrees of protection for humans against viral diseases not yet vaccine preventable, such as human papillomavirus and herpes simplex. The tools of vaccination are being applied therapeutically for various cancers and chronic conditions.
The Eighth Annual Conference on Vaccine Research will provide the opportunity to receive high-quality, current reports of scientific progress featured in both invited presentations and submitted abstracts. The disparate fields covered in both human and veterinary vaccinology encourage valuable cross-fertilization of ideas and approaches among researchers otherwise focused on specific diseases or methods. The Conference has become the largest scientific meeting devoted exclusively to research on vaccines and associated technologies for disease prevention and treatment through immunization. The Eighth Annual Conference promises to maintain this tradition as the premier venue for cutting edge topics and issues. International experts will lead seminars and panel discussions on topical areas of basic immunology, product development, clinical testing, regulation, and other aspects of vaccine research. Opportunities for networking and scientific collaboration critical to advancing vaccine science and development will be available through audience discussions, poster presentations, sponsored exhibits, and evening ceremonies and receptions. For further information, visit www.nfid.org/conferences/ vaccine05.
Measuring Behavior 2005 -5th International Conference on Methods and Techniques in Behavioural Research
30 August-2 September 2005 (Wageningen, The Netherlands) Measuring Behavior is the fifth conference specifically addressing methods and techniques in behavioural research. It is the premier interdisciplinary event for scientists and practitioners concerned with human or animal behaviour. Presentations will include topics related to methodological aspects of behavioural investigations, including newly developed methods and techniques, innovative applications of existing techniques and assessment and application of established methods. Further information is available from www.noldus.com/ mb2005.
ANZCCART 2005 Conference: Animal Ethics
Committees and Animal Use in a Monitored Environment: Is the Ethics Real, Imagined or Necessary?
26-28 June 2005 (Wellington, New Zealand) The theme of the conference is one that acknowledges the buy-in at multiple levels when a scientist suggests a project that involves the use of animals. The monitored environment stated in the title should be viewed as personal, committee-based, institutional, legal, as well as public. There is also the concept of trying to establish best practice, which moves the discussion to an ill-defined high ground. This concept is meant to challenge the conference participants to discuss how animal ethics committees work, what their role should be, and the way scientists scope their research and interact with a committee process that acts as the gate keeper. In this way, the conference can cover the real, imagined and necessary aspects of an animal ethics committee, together with the justification and manner in which animals are manipulated in the laboratory and the field. For further information visit www.adelaide.edu.au/ANZCCART/ publications/ANZCCART%202005% 20CONFERENCE.pdf.
Information and reports available
European Research Council An EC document prepared by the Commission and the Organization for Heads of Research Councils (EUROHORCS) has outlined the proposed structure and functions of a future European Research Council (ERC). It incorporates qualities advocated by the research community and recommends that applications be open to all disciplines; grants should take account of the full economic cost of performing the work at the applying institution. In the coming months the EC proposes to address three outstanding issues: the most appropriate structure; the establishment of a governing Council; and the operational framework. The EU research commissionerdesignate warned that the proposed doubling of the EU research budget to fund the proposals could lead national governments to cut their own programmes and called for governments to ringfence their current spending. A meeting hosted by UNESCO for European scientists discussed how the scheme might operate. Two problems received particular attention and remained to be resolved: how to avoid a damaging high rejection rate for grant applications, and how to create a governance structure that would be independent of bureaucrats in Brussels. Luc Van Dyck, from the European Life Sciences Forum, has recommended that the initial programme of an ERC should focus predominantly on supporting young investigators who are establishing their first independent group. This would put all countries on an equal footing, help overcome the fears of politicians about an absence of juste retour in the arrangements and reduce the number of applicants.
New website launched by ACLAM and AAALAC ACLAM and AAALAC have announced a new service to facilitate the free exchange of information among laboratory animal medicine professionals around the world -the Laboratory Animal Veterinary Information Network (www.labanimalvet.info). This is not a discussion list. Instead, it is a place to pose a specific question to an expert, who may answer or put you in touch with an individual, agency or institution in a particular country best suited to answer your question. This site is a voluntary, noncommercial service, so there is no guaranteed turnaround time. Questions will be answered by volunteer experts as quickly as they are able to address them. This web-based service allows colleagues to ask fellow veterinary professionals country-specific questions on issues such as health, welfare, transportation, import/export procedures, animal health certificates, shipment of tissue samples, and other topics. The purpose of this website is not intended to deal with general facility or operational questions, but rather to complement other well-established communication links such as COMPMED.
Comments

New technology platform for animal health launched
The European Commission has announced a technology platform on 'Global Animal Health'. It takes the form of a partnership led by industry and supported by EU Commissioners for Development, Science and Research and Consumer Protection. It will create a partnership covering the whole chain, from innovation to delivery of new vaccines and tests and is intended to contribute to improvements in animal health and welfare, food safety, human health and market access, particularly by developing countries. The EU currently supports research into major diseases of livestock such as foot-andmouth disease, avian influenza, classical swine fever, African swine fever, rinderpest, bluetongue. Research is principally focused on diagnostics tests, vaccines, epidemiology and biosafety. The platform brings together veterinary pharmaceutical and small biotechnology companies, research institutions, the financial world and the regulatory authorities at the European level. The project will be industry driven to develop and deliver the most up-to-date tools, such as new vaccines or tests to control major animal diseases.
Scientific approach to housing and husbandry wins top welfare prize Dr Robert Hubrecht has been awarded the GlaxoSmithKline Laboratory Animal Welfare Prize for his scientific approach to, and promotion of, improvements in husbandry and housing for laboratory animals. The prize is awarded every year by RDS and comprises £2000 and an engraved plaque. Dr Hubrecht is Deputy Director of the UK Universities Federation for Animal Welfare (UFAW). He carried out research at Cambridge University into the welfare of kennelled dogs, work which resulted in practical recommendations for improving their housing and environment to meet social and other behavioural needs. Dr Hubrecht has been influential in promoting a scientific approach to housing and husbandry together in laboratories. He has been active in stimulating research into animal welfare and has prompted several collaborative research projects, examining the welfare implications of noise in kennels, the transport of primates and most recently the social grouping of monkeys. A particularly important innovation has been the establishment of the Pharmaceutical Housing and Husbandry Steering Committee (PHHSC) in which laboratory animal breeders, pharmaceutical companies, contract research organizations and Laboratory Animals (2005) 39 welfare organizations cooperate to fund animal welfare studentships.
Dr Hubrecht serves on the Animal Procedures Committee, which advises the Home Secretary on the application of the Animals (Scientific Procedures) Act 1986. He is Chair of the Housing and Husbandry Sub-Committee, a member of the Primates Sub-Committee, and serves on several APC working groups.
FELASA comments on REACH proposals
On 29 October 2003, the European Commission adopted a proposal for the new European Union regulatory framework for chemicals, REACH (Registration, Evaluation and Authorisation of CHemicals). Enterprises that manufacture or import chemical substances are required to register such activities in a central database. REACH gives greater responsibility to industry to manage the risks from chemicals and to provide safety information on the substances. A huge number of laboratory animals is potentially involved. Whilst accepting the need to explore environmental and health risks related with chemicals, FELASA argued that testing should adopt validated methods that avoid the use of live animals. When alternative methods are not feasible, only experiments with the highest scientific standards should be conducted and all possible actions taken to reduce numbers of animals and the potential suffering. Chemicals should not be tested or retested in animals if they are well known and are expected not to cause harm to the environment, to animals and/or to humans. The Federation supported a tier-testing scheme proposed by the UK Fund for the Replacement of Animals in Medical Experiments, which argued that: Mink raft wins first UFAW Wild Animal Welfare Award The first Wild Animal Welfare Award given by the UK charity UFAW (the Universities Federation for Animal Welfare) has been won by Dr Jonathan Reynolds of The Game Conservancy Trust for his innovative mink raft which allows the predators to be trapped without harming other species. Ben Bradshaw, Minister for Nature Conservation and Fisheries, presented the £1000 award on 7 September 2004. The UFAW award recognizes innovations that are relevant to improving the welfare of captive wild animals or which alleviate or prevent harm of human origin to animals in the wild.
Invited referees
The Editorial Board is most grateful to the many referees who have helped in assessing papers submitted to Laboratory Animals. The Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org) will be used as a guide for matters not covered by these Notes to Authors. Letters to the Editor will be considered for publication, but only on issues related to the scientific or ethical content of the journal, and authors will be given the opportunity to publish a reply to any letters. All contributions are reviewed by independent referees, and the final decision on acceptance or rejection remains with the Editorial Board. The authors of papers accepted for publication will be required to assign copyright to Laboratory Animals Ltd, and a form for this purpose will accompany the proofs.
Submissions
Manuscripts must be accompanied by a covering letter signed by ALL authors confirming (a) that they consent to publication, and (b) that the paper is not under consideration/accepted for publication or already published elsewhere. One author should be designated to receive correspondence and a contact email address must be supplied. Manuscripts should be prepared in accordance with the guidelines below and should be sent by post: one copy should be on floppy disk or CD-ROM (together with digital images of any figures) and three copies printed on paper. They should be sent to: 
References
Only essential references should be included and authors should verify them against the original documents. The Harvard system should be used: cite authors' surnames and dates of publication in the text, and provide a list of references at the end arranged alphabetically by first author surname. Where there are three or more authors, the text citation should be the name of the first author followed by et al. References to several works by the same author(s) published in the same year should be differentiated by letters a, b, etc. after the date.
The list of references should include the following information:
Each reference in the list should include the names and initials of all authors (unless there are more than six, in which case only the first three should be given, followed by et al.). Publications for which no author is apparent may be attributed to the organization from which they originate. Papers accepted for publication but not yet published should be included in the list of references, followed by '(in press)'. Papers in preparation, personal communications and unpublished observations should be referred to as such in the text only.
Tables
Tables should not duplicate information given in the text or illustrations. The tables feature of the word processor should be used to prepare them. They should be numbered in the order in which they are mentioned in the text, each be given a brief title, and each appear on a separate page at the end of the manuscript as part of the text file. Vertical rules and/or background shading should not be used.
Illustrations
All illustrations (Figures) should be black and white, and should be numbered in the order in which they are mentioned in the text. Each Figure  must be saved in a separate file and printouts of these appended to the manuscript. All illustrations should be provided in 'camera-ready form' with redundant areas removed. Line 'drawings' should be professionally prepared and labelled (freehand lettering is not acceptable).
Charts (e.g. histograms and graphs) may be supplied as Excel spreadsheets (preferably one spreadsheet per chart). Other line figures (e.g. maps and flow charts) should be supplied as TIFF files or in WMF format. Photographic images should be supplied as TIFF files at a resolution of at least 600 dpi. Micrographs should have a bar to indicate the magnification. Any lettering/ numbering should be sufficiently large to ensure legibility after reduction for publication, i.e. reduction to a width of 69 mm (one column width) or 142 mm (page width). One set of black and white photographs (labelled on the back with the name of first author, Figure number, short title of paper and date of submission) should be supplied for any images on the disk that are not line 'drawings'.
The list of figure legends (one for each Figure) should appear on a separate page at the end of the manuscript as part of the text file. Staining techniques and the magnification of micrographs should be stated, and arrows/abbreviations explained. Any illustrations previously published should be accompanied by the written consent of the copyright holder to replication, an acknowledgement included in the legend and the full reference included in the list.
Colour illustrations can be included, but the additional costs involved will be at the authors' expense.
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Proofs will be sent by email to the designated corresponding author as a PDF file attachment, and should be corrected and returned promptly by fax or post; corrections should be kept to a minimum.
Fifty free offprints of each article will be supplied; additional offprints may be ordered from the publisher when the proofs are returned. Orders received after this time cannot be fulfilled. Address business correspondence to the Editorial Manager, Laboratory Animals, The Royal Society of Medicine Press Limited, as above.
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